ImmuCell Corporation Company Profile (NASDAQ:ICCC)

About ImmuCell Corporation

ImmuCell Corporation logoImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICCC
  • CUSIP:
Key Metrics:
  • Previous Close: $5.52
  • 50 Day Moving Average: $5.94
  • 200 Day Moving Average: $6.52
  • 52-Week Range: $4,847,000.00 - $4.76
  • Trailing P/E Ratio: 46.00
  • P/E Growth: 0.00
  • Market Cap: $26.76M
  • Outstanding Shares: 4,847,000
  • Beta: 0.81
Profitability:
  • Net Margins: 5.32%
  • Return on Equity: 3.11%
  • Return on Assets: 2.48%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 12.13%
  • Quick Ratio: 10.46%
Additional Links:
Companies Related to ImmuCell Corporation:

Analyst Ratings

Consensus Ratings for ImmuCell Corporation (NASDAQ:ICCC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ImmuCell Corporation (NASDAQ:ICCC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ImmuCell Corporation (NASDAQ:ICCC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017        
2/9/2017Q416$0.01$2.70 million$2.20 millionViewListenView Earnings Details
11/10/2016Q316$0.01$1.61 million$1.97 millionViewN/AView Earnings Details
5/11/2016Q1$0.11$2.99 millionViewN/AView Earnings Details
2/10/2016Q315$0.09$2.21 million$2.70 millionViewListenView Earnings Details
2/11/2015Q414$0.04$1.56 million$2.21 millionViewN/AView Earnings Details
8/12/2014Q214($0.10)$1.37 million$1.54 millionViewN/AView Earnings Details
2/13/2014Q413($0.05)$1.42 million$1.56 millionViewN/AView Earnings Details
11/12/2013Q313$0.02$1.08 million$1.24 millionViewN/AView Earnings Details
11/7/2012Q312($0.02)$1.00 million$1.08 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmuCell Corporation (NASDAQ:ICCC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmuCell Corporation (NASDAQ:ICCC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ImmuCell Corporation (NASDAQ:ICCC)
Insider Ownership Percentage: 23.20%
Institutional Ownership Percentage: 14.60%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/7/2016David Scott TomscheDirectorBuy4,000$5.19$20,760.00View SEC Filing  
7/8/2016Joseph H CrabbVPSell1,935$6.55$12,674.25View SEC Filing  
7/7/2016Joseph H CrabbVPSell2,691$6.58$17,706.78View SEC Filing  
7/5/2016Joseph H CrabbVPSell5,374$6.74$36,220.76View SEC Filing  
3/21/2016David Scott TomscheDirectorBuy955$6.67$6,369.85View SEC Filing  
1/29/2016David CunninghamDirectorBuy1,904$5.25$9,996.00View SEC Filing  
9/3/2015Jonathan E. RothschildDirectorBuy3,000$6.63$19,890.00View SEC Filing  
9/1/2015David Scott TomscheDirectorBuy1,000$6.73$6,730.00View SEC Filing  
8/31/2015Jonathan E. RothschildDirectorBuy6,100$7.37$44,957.00View SEC Filing  
8/28/2015David Scott TomscheDirectorBuy1,500$7.27$10,905.00View SEC Filing  
11/26/2014Jonathan E RothschildDirectorBuy2,100$4.82$10,122.00View SEC Filing  
8/20/2014Jonathan E RothschildDirectorBuy3,000$4.55$13,650.00View SEC Filing  
6/16/2014Jonathan E RothschildDirectorBuy5,901$4.57$26,967.57View SEC Filing  
5/15/2014David CunninghamDirectorBuy1,500$3.91$5,865.00View SEC Filing  
8/23/2013Jonathan E RothschildDirectorBuy1,500$3.98$5,970.00View SEC Filing  
8/16/2013David CunninghamDirectorBuy4,000$3.68$14,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ImmuCell Corporation (NASDAQ:ICCC)
DateHeadline
News IconImmuCell sales dip in 2016 (NASDAQ:ICCC)
www.pressherald.com - February 14 at 7:10 PM
capitalcube.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017 (NASDAQ:ICCC)
www.capitalcube.com - February 14 at 7:10 PM
seekingalpha.com logoImmuCell Corporation (ICCC) (NASDAQ:ICCC)
seekingalpha.com - February 11 at 5:53 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ICCC)
biz.yahoo.com - February 10 at 6:34 PM
biz.yahoo.com logoQ4 2016 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - February 9 at 6:43 PM
finance.yahoo.com logoImmuCell Announces Preliminary 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - February 9 at 6:43 PM
finance.yahoo.com logoImmuCell to Announce Preliminary 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - February 6 at 5:54 PM
capitalcube.com logoImmuCell Corp.: Strong price momentum but will it sustain? (NASDAQ:ICCC)
www.capitalcube.com - December 2 at 5:40 PM
finance.yahoo.com logoIMMUCELL CORP /DE/ Financials (NASDAQ:ICCC)
finance.yahoo.com - November 18 at 5:03 PM
capitalcube.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 (NASDAQ:ICCC)
www.capitalcube.com - November 14 at 5:48 PM
seekingalpha.com logoImmuCell's (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call Transcript (NASDAQ:ICCC)
seekingalpha.com - November 12 at 8:02 AM
streetinsider.com logoImmucell Corp (ICCC) Reports Q3 EPS of $0.01 (NASDAQ:ICCC)
www.streetinsider.com - November 12 at 8:02 AM
einnews.com logoImmuCell Announces Third Quarter 2016 Financial Results (NASDAQ:ICCC)
automotive.einnews.com - November 11 at 5:07 PM
News IconImmuCell product sales, net income down in third quarter (NASDAQ:ICCC)
www.pressherald.com - November 11 at 5:07 PM
marketwired.com logoImmuCell to Present at the 7th Annual Craig-Hallum Alpha Select Conference (NASDAQ:ICCC)
www.marketwired.com - November 11 at 5:07 PM
publicnow.com logo11-03-2016 ImmuCell to Announce Third Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - November 3 at 5:28 PM
finance.yahoo.com logoImmuCell to Announce Third Quarter 2016 Financial Results Conference Call Scheduled for Thursday, November 10, 2016 at 4:30 PM ET (NASDAQ:ICCC)
finance.yahoo.com - November 3 at 8:57 AM
finance.yahoo.com logoImmuCell Corporation Announces Closing of $3.5 Million Private Placement of Common Stock (NASDAQ:ICCC)
finance.yahoo.com - October 21 at 5:39 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:ICCC)
biz.yahoo.com - October 21 at 5:39 PM
publicnow.com logo10-21-2016 ImmuCell Corporation Announces Closing of $3.5 Million Private Placement of Common Stock (NASDAQ:ICCC)
www.publicnow.com - October 21 at 5:39 PM
News IconImmuCell seeks private investment to complete new production facility (NASDAQ:ICCC)
www.vcpost.com - October 19 at 10:27 AM
News IconImmuCell seeks $3.5 million from private investors to complete new facility (NASDAQ:ICCC)
www.pressherald.com - October 19 at 10:27 AM
fxpips.com logoGaps Down – STBA, TCCO, OREX, ICCC, BMI, CPSS, FLOW (NASDAQ:ICCC)
www.fxpips.com - October 19 at 10:27 AM
streetinsider.com logoImmucell Corp (ICCC) Offers Prelim. Q3 Results; Says Sales Fell 20% (NASDAQ:ICCC)
www.streetinsider.com - October 19 at 10:27 AM
streetinsider.com logoImmuCell Announces Preliminary Third Quarter 2016 Financial Results (NASDAQ:ICCC)
www.streetinsider.com - October 18 at 10:37 AM
marketwatch.com logoImmuCell to Raise $3.5 Million in Private Placement (NASDAQ:ICCC)
www.marketwatch.com - October 18 at 10:37 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:ICCC)
biz.yahoo.com - October 18 at 10:37 AM
publicnow.com logo10-18-2016 ImmuCell Announces Preliminary Third Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - October 18 at 10:37 AM
publicnow.com logo10-18-2016 ImmuCell to Raise $3.5 Million in Private Placement (NASDAQ:ICCC)
www.publicnow.com - October 18 at 10:37 AM
News IconImmuCell Breaks Ground for Mast Out(R) Facility (NASDAQ:ICCC)
www.wallstreet-online.de - October 11 at 5:44 PM
marketwired.com logoImmuCell Breaks Ground for Mast Out® Facility (NASDAQ:ICCC)
www.marketwired.com - October 11 at 5:44 PM
publicnow.com logo10-11-2016 ImmuCell Breaks Ground for Mast Out® Facility (NASDAQ:ICCC)
www.publicnow.com - October 11 at 5:44 PM
News IconHiring conditions proposed for Portland TIF projects (NASDAQ:ICCC)
www.mainebiz.biz - September 8 at 5:27 PM
News IconImmuCell records loss despite increase in sales (NASDAQ:ICCC)
www.mainebiz.biz - August 16 at 5:44 PM
capitalcube.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:ICCC)
www.capitalcube.com - August 15 at 5:47 PM
News IconImmuCell reports 21 percent sales increase in second quarter (NASDAQ:ICCC)
www.pressherald.com - August 13 at 8:31 AM
finanznachrichten.de logoImmuCell Announces Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.finanznachrichten.de - August 13 at 8:31 AM
seekingalpha.com logoImmuCell's (ICCC) CEO Michael Brigham on Q2 2016 Results - Earnings Call Transcript (NASDAQ:ICCC)
seekingalpha.com - August 13 at 8:31 AM
streetinsider.com logoImmucell Corp (ICCC) Reports Q2 EPS of $0.00 (NASDAQ:ICCC)
www.streetinsider.com - August 13 at 8:31 AM
publicnow.com logo08-11-2016 ImmuCell Announces Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - August 11 at 5:48 PM
biz.yahoo.com logoQ2 2016 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - August 11 at 8:36 AM
publicnow.com logo08-03-2016 “ImmuCell to Announce Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - August 4 at 5:53 PM
finance.yahoo.com logoImmuCell to Announce Second Quarter 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - August 3 at 5:52 PM
News IconVP & Chief Scientific Officer of ImmuCell Corporation (NASDAQ:ICCC), Crabb Joseph H, sells 1,935 shares worth $12,669 (NASDAQ:ICCC)
empowerednews.net - July 12 at 5:51 PM
News IconImmuCell looks to tax break to aid in Portland expansion (NASDAQ:ICCC)
www.mainebiz.biz - July 6 at 10:15 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements an (NASDAQ:ICCC)
biz.yahoo.com - June 16 at 3:35 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:ICCC)
biz.yahoo.com - June 15 at 4:47 PM
finance.yahoo.com logoImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations (NASDAQ:ICCC)
finance.yahoo.com - April 4 at 5:40 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balanc (NASDAQ:ICCC)
biz.yahoo.com - March 31 at 5:07 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report (NASDAQ:ICCC)
biz.yahoo.com - March 25 at 9:17 AM

Social

What is ImmuCell Corporation's stock symbol?

ImmuCell Corporation trades on the NASDAQ under the ticker symbol "ICCC."

When will ImmuCell Corporation announce their earnings?

ImmuCell Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, May, 9th 2017.

How do I buy ImmuCell Corporation stock?

Shares of ImmuCell Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of ImmuCell Corporation stock cost?

One share of ImmuCell Corporation stock can currently be purchased for approximately $5.52.

ImmuCell Corporation (NASDAQ:ICCC) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for ImmuCell Corporation (NASDAQ:ICCC)

Earnings History Chart

Earnings by Quarter for ImmuCell Corporation (NASDAQ:ICCC)

Dividend History Chart

Dividend Payments by Quarter for ImmuCell Corporation (NASDAQ:ICCC)

Last Updated on 2/20/2017 by MarketBeat.com Staff